Nexus Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $31.7M | Sell |
251,016
-3,706
| -1% | -$488K | 4.14% | 11 |
|
|
2026
Q1 | $35.5M | Sell |
254,722
-3,102
| -1% | -$434K | 4.96% | 8 |
|
|
2025
Q4 | $31.6M | Sell |
257,824
-1,200
| -0.5% | -$146K | 4.31% | 11 |
|
|
2025
Q3 | $28.8M | Buy |
259,024
+21,220
| +9% | +$2.41M | 4.08% | 11 |
|
|
2025
Q2 | $26.4M | Sell |
237,804
-3,905
| -2% | -$416K | 3.94% | 10 |
|
|
2025
Q1 | $39M | Buy |
241,709
+1,896
| +0.8% | +$196K | 4.41% | 11 |
|
|
2024
Q4 | $22.2M | Sell |
239,813
-43,250
| -15% | -$3.89M | 2.22% | 22 |
|
|
2024
Q3 | $23.7M | Sell |
283,063
-5,355
| -2% | -$409K | 2.33% | 23 |
|
|
2024
Q2 | $19.8M | Sell |
288,418
-1,060
| -0.4% | -$70.7K | 2.08% | 26 |
|
|
2024
Q1 | $21.2M | Sell |
289,478
-500
| -0.2% | -$38.4K | 2.04% | 28 |
|
|
2023
Q4 | $23.5M | Sell |
289,978
-1,990
| -0.7% | -$155K | 2.45% | 25 |
|
|
2023
Q3 | $21.9M | Buy |
291,968
+455
| +0.2% | +$35K | 2.47% | 21 |
|
|
2023
Q2 | $22.5M | Sell |
291,513
-1,955
| -0.7% | -$156K | 2.45% | 25 |
|
|
2023
Q1 | $24.3M | Sell |
293,468
-750
| -0.3% | -$62.1K | 2.69% | 20 |
|
|
2022
Q4 | $25.3M | Buy |
294,218
+15,425
| +6% | +$1.22M | 2.85% | 17 |
|
|
2022
Q3 | $17.2M | Buy |
278,793
+2,875
| +1% | +$181K | 2.14% | 24 |
|
|
2022
Q2 | $17.1M | Sell |
275,918
-37,550
| -12% | -$2.32M | 1.96% | 26 |
|
|
2022
Q1 | $18.6M | Buy |
313,468
+2,950
| +1% | +$189K | 1.96% | 25 |
|
|
2021
Q4 | $22.5M | Sell |
310,518
-1,800
| -0.6% | -$124K | 2.29% | 23 |
|
|
2021
Q3 | $21.8M | Sell |
312,318
-3,078
| -1% | -$216K | 2.36% | 22 |
|
|
2021
Q2 | $21.7M | Buy |
315,396
+4,525
| +1% | +$302K | 2.24% | 25 |
|
|
2021
Q1 | $20.1M | Buy |
310,871
+18,655
| +6% | +$1.2M | 2.29% | 24 |
|
|
2020
Q4 | $16.7M | Buy |
292,216
+1,275
| +0.4% | +$76.9K | 2.15% | 24 |
|
|
2020
Q3 | $18.4M | Buy |
290,941
+1,975
| +0.7% | +$137K | 2.78% | 21 |
|
|
2020
Q2 | $22.2M | Sell |
288,966
-18,300
| -6% | -$1.4M | 3.42% | 16 |
|
|
2020
Q1 | $23M | Buy |
307,266
+4,450
| +1% | +$307K | 4.05% | 10 |
|
|
2019
Q4 | $19.7M | Buy |
302,816
+29,775
| +11% | +$1.94M | 2.69% | 20 |
|
|
2019
Q3 | $17.3M | Sell |
273,041
-3,250
| -1% | -$212K | 2.46% | 21 |
|
|
2019
Q2 | $18.7M | Buy |
276,291
+6,820
| +3% | +$449K | 2.59% | 19 |
|
|
2019
Q1 | $17.5M | Buy |
269,471
+6,225
| +2% | +$414K | 2.59% | 19 |
|
|
2018
Q4 | $16.5M | Buy |
263,246
+1,823
| +0.7% | +$127K | 2.88% | 17 |
|
|
2018
Q3 | $20.2M | Buy |
261,423
+32
| +0% | +$2.42K | 2.89% | 15 |
|
|
2018
Q2 | $18.5M | Buy |
261,391
+2,050
| +0.8% | +$145K | 2.75% | 16 |
|
|
2018
Q1 | $19.6M | Buy |
259,341
+700
| +0.3% | +$55.6K | 3% | 15 |
|
|
2017
Q4 | $18.5M | Buy |
258,641
+225
| +0.1% | +$17.1K | 2.75% | 19 |
|
|
2017
Q3 | $20.9M | Buy |
258,416
+3,300
| +1% | +$252K | 3.27% | 14 |
|
|
2017
Q2 | $18.1M | Buy |
255,116
+1,950
| +0.8% | +$130K | 2.94% | 17 |
|
|
2017
Q1 | $17.2M | Buy |
253,166
+18,150
| +8% | +$1.28M | 2.93% | 18 |
|
|
2016
Q4 | $16.8M | Buy |
235,016
+21,500
| +10% | +$1.6M | 2.86% | 18 |
|
|
2016
Q3 | $16.9M | Buy |
213,516
+11,675
| +6% | +$948K | 3.08% | 17 |
|
|
2016
Q2 | $16.8M | Buy |
201,841
+2,991
| +2% | +$265K | 3.21% | 15 |
|
|
2016
Q1 | $18.3M | Buy |
198,850
+8,300
| +4% | +$748K | 3.45% | 9 |
|
|
2015
Q4 | $19.3M | Buy |
190,550
+1,875
| +1% | +$195K | 3.87% | 8 |
|
|
2015
Q3 | $18.5M | Buy |
188,675
+900
| +0.5% | +$100K | 3.88% | 8 |
|
|
2015
Q2 | $22M | Sell |
187,775
-2,265
| -1% | -$247K | 4.27% | 5 |
|
|
2015
Q1 | $18.6M | Sell |
190,040
-900
| -0.5% | -$91.4K | 3.67% | 8 |
|
|
2014
Q4 | $18M | Sell |
190,940
-6,300
| -3% | -$652K | 3.37% | 11 |
|
|
2014
Q3 | $21M | Sell |
197,240
-2,075
| -1% | -$203K | 3.96% | 4 |
|
|
2014
Q2 | $16.5M | Buy |
199,315
+10,650
| +6% | +$829K | 3.07% | 14 |
|
|
2014
Q1 | $13.4M | Buy |
188,665
+12,500
| +7% | +$980K | 2.61% | 21 |
|
|
2013
Q4 | $13.2M | Buy |
176,165
+35,650
| +25% | +$2.48M | 2.66% | 23 |
|
|
2013
Q3 | $8.83M | Buy |
140,515
+134,515
| +2,242% | +$8.04M | 1.88% | 28 |
|
|
2013
Q2 | $322K | Buy |
+6,000
| New | +$313K | 0.07% | 55 |
|
Other funds holding GILD
Nexus Investment Management's GILD Position: Q2 2026 in Review
Nexus Investment Management reduced its Gilead Sciences (GILD) stake by 1.5% in Q2 2026, selling an estimated $488K and leaving 251,016 shares worth $31.7M. The position accounts for 4.14% of the portfolio, ranked #11.
Nexus Investment Management first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $39M in Q1 2025. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Nexus Investment Management held 251,016 shares of Gilead Sciences worth $31.7M as of Q2 2026.
- Nexus Investment Management sold 3,706 Gilead Sciences shares in Q2 2026, an estimated $488K.
- Gilead Sciences made up 4.14% of Nexus Investment Management's portfolio in Q2 2026, its #11 holding.
- Nexus Investment Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Nexus Investment Management's Gilead Sciences position peaked at $39M in Q1 2025.
- 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Nexus Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.